Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 2/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Asthma, Chronic fatigue syndrome, Coeliac disease, Sensory disturbance, Bedridden, Cognitive disorder, Postural orthostatic tachycardia syndrome
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Hospitalized? Yes, days:
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control no. GB-1577272925-2016010090) on 11-OCT-2016. This report was received from the agency on 06-Oct-2016 under reference number GB-MHRA-ADR 23667457. Case received from a consumer/other non health professional concerning a 13-year-old female adolescent patient who received GARDASIL, batch number unknown via parenteral route on an unknown date. The patient experienced chronic fatigue syndrome, postural orthostatic tachycardia syndrome, allergic asthma, coeliac disease, cognitive disorder (patient could not read or watch television), sensory disturbance (extreme sensitivity to sense stimuli) and bedridden on an unknown date. The patient was admitted to hospital on an unspecified date. The outcome of chronic fatigue syndrome was recovered/resolved with sequelae, postural orthostatic tachycardia syndrome, allergic asthma, coeliac disease was not recovered/not resolved, cognitive disorder, sensory disturbance and bedridden was unknown. The patient patient''s overall outcome was reported as unknown.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166